We have shown, that CLDN3, CLDN4 and CLDN7 mRNA expression is significantly higher in IMPC tumors compared to the IBC-NST group, while CLDN1 showed significantly lower mRNA expression in the IMPC group. This evidence concerns the gene CLDN3 and inflammatory breast carcinoma.